New Nordic Healthbrands AB (publ) NNH.ST
Nasdaq Stockholm · Consumer Defensive · Packaged Foods
15.00 SEK
+2.4%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for New Nordic Healthbrands
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 488 | 534 | 550 | 576 |
| EBITDA | −2 | −2 | −1 | 17 |
| Net income | −3 | −6 | −8 | 8 |
| Balance sheet | ||||
| Equity | 113 | 106 | 101 | 103 |
| Total debt | 48 | 27 | 37 | 34 |
| Cash | 11 | 14 | 15 | 17 |
| Net debt | 38 | 13 | 22 | 17 |
| Ratios and per share | ||||
| EBITDA margin | −0.4% | −0.3% | −0.3% | 3.0% |
| Profit margin | −0.6% | −1.2% | −1.4% | 1.4% |
| Return on equity | −2.5% | −5.8% | −7.6% | 7.9% |
| Earnings/share (SEK) | −0.46 | −1.00 | −1.24 | 1.32 |
| Book value/share (SEK) | 18.17 | 17.11 | 16.29 | 16.70 |
| Shares outstanding (M) | 6 | 6 | 6 | 6 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 11.3 |
| P/B | 0.9 |
| EV / EBITDA | 6.4 |
| Net debt / EBITDA | 1.0 |
| Return on equity | 7.9% |
| Profit margin | 1.4% |
| Beta 1Y | 0.25 |
| Revenue growth 1Y | +4.7% |
| Revenue CAGR 3Y | +5.7% |
| ROE avg. 3Y | −1.9% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 0.25 |
| 2022 | 1.25 |
Not investment advice. Figures may contain errors from the data source.